KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $9.0 million.

  • Pfizer's Income from Non-Controlling Interests rose 1250.0% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year increase of 2812.5%. This contributed to the annual value of $31.0 million for FY2024, which is 2051.28% down from last year.
  • Pfizer's Income from Non-Controlling Interests amounted to $9.0 million in Q3 2025, which was up 1250.0% from $18.0 million recorded in Q2 2025.
  • Pfizer's Income from Non-Controlling Interests' 5-year high stood at $26.0 million during Q3 2021, with a 5-year trough of $6.0 million in Q2 2022.
  • Over the past 5 years, Pfizer's median Income from Non-Controlling Interests value was $9.0 million (recorded in 2021), while the average stood at $10.6 million.
  • Per our database at Business Quant, Pfizer's Income from Non-Controlling Interests skyrocketed by 22500.0% in 2021 and then crashed by 7692.31% in 2022.
  • Quarter analysis of 5 years shows Pfizer's Income from Non-Controlling Interests stood at $12.0 million in 2021, then increased by 25.0% to $15.0 million in 2022, then plummeted by 40.0% to $9.0 million in 2023, then dropped by 11.11% to $8.0 million in 2024, then rose by 12.5% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $18.0 million for Q2 2025, and $6.0 million during Q1 2025.